Inhibitors

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information
Structure Chemical Name CAS MF
Marilixibat chloride Marilixibat chloride 228113-66-4 C40H56ClN3O4S
Flumatinib mesylate Flumatinib mesylate 895519-91-2 C30H33F3N8O4S
Sparsentan (RE-021) Sparsentan (RE-021) 254740-64-2 C32H40N4O5S
tesofensine tesofensine 195875-84-4 C17H23Cl2NO
LC242 LC242 187585-64-4 C37H36O14
1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]- 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]- 92206-54-7 C19H25NOS
Plitidepsin Plitidepsin 137219-37-5 C57H87N7O15
Probenecid sodium Probenecid sodium 23795-03-1
E7130 E7130 2220148-40-1 C58H83NO17
Medetomidine Medetomidine 86347-14-0 C13H16N2
BMS-986205 BMS-986205 1923833-60-6 C24H24ClFN2O
MKC9989 MKC9989 1338934-20-5 C17H20O7
Grapiprant Grapiprant 415903-37-6 C26H29N5O3S
Futibatinib Futibatinib 1448169-71-8 C22H22N6O3
Pyrotinib Maleate Pyrotinib Maleate 1397922-61-0 C40H39ClN6O11
GSK872 GSK872 1346546-69-7 C19H17N3O2S2
PF06869206 PF06869206 2227425-05-8 C15H14ClF3N4O2
Granisetron hydrochloride Granisetron hydrochloride 1224925-76-1 C18H21D3N4O
BI-0474 BI-0474 2750570-55-7 C30H37N9O2S
hygromycin A hygromycin A 6379-56-2 C23H29NO12
2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol 2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol 128607-22-7 C24H23ClO2
CJC1295 CJC1295 863288-34-0 C152H252N44O42
Disitertide Disitertide 272105-42-7 C68H109N17O22S2
NU1025 NU1025 90417-38-2 C9H8N2O2
PHA 767491 HYDROCHLORIDE PHA 767491 HYDROCHLORIDE 845714-00-3 C12H11N3O
ETHYL 8-METHOXY-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE-4-CARBOXYLATE ETHYL 8-METHOXY-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE-4-CARBOXYLATE 869363-13-3 C25H15ClF2N4O2
CYC-116 CYC-116 693228-63-6 C18H20N6OS
VX 702 VX 702 745833-23-2 C19H12F4N4O2
BMS-754807 BMS-754807 1001350-96-4 C23H24FN9O
4-Chloro-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]benzamide 4-Chloro-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]benzamide 188591-46-0 C15H12ClF3N2O3S
PH 797804 PH 797804 586379-66-0 C22H19BrF2N2O3
PF03716556 PF03716556 928774-43-0 C22H26N4O3
PF 477736 PF 477736 952021-60-2 C22H25N7O2
CCT129202 CCT129202 942947-93-5 C23H25ClN8OS
Alectinib Hydrochloride Alectinib Hydrochloride 1256589-74-8 C30H35ClN4O2
PF-03814735 PF-03814735 942487-16-3 C23H25F3N6O2
CH5132799 CH5132799 1007207-67-1 C15H19N7O3S
Abemaciclib mesylate (LY2835219) Abemaciclib mesylate (LY2835219) 1231930-82-7 C28H36F2N8O3S
PRT062607 (Hydrochloride) PRT062607 (Hydrochloride) 1370261-97-4 C19H24ClN9O
1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide 1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide 1396772-26-1 C32H37N5O3
RN486 RN486 1242156-23-5 C35H35FN6O3
AVL-292 AVL-292 1202757-89-8 C22H22FN5O3
PD0332991 Isethionate PD0332991 Isethionate 827022-33-3 C26H35N7O6S
AZD-1208 AZD-1208 1204144-28-4 C21H21N3O2S
UNC 1999 UNC 1999 1431612-23-5 C33H43N7O2
UNC 0631 UNC 0631 1320288-19-4 C37H61N7O2
4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide 4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide 312756-74-4 C20H16Br2N2O3S
AA41612 AA41612 433690-62-1 C12H15Cl2NO3S
Btk Kinase inhibitor Btk Kinase inhibitor 1351636-18-4 C25H22N6O3
CFTRinh-172 CFTRinh-172 307510-92-5 C18H10F3NO3S2
GS-441524 GS-441524 1191237-69-0 C12H13N5O4
Capmatinib hydrochloride Capmatinib hydrochloride 1865733-40-9 C23H20ClFN6O2
LY310762 LY310762 192927-92-7 C24H27O2N2FHCl
IMD-0354 IMD-0354 978-62-1 C15H8ClF6NO2
BAY 11-7085 BAY 11-7085 196309-76-9 C13H15NO2S
RG108 RG108 48208-26-0 C19H14N2O4
TCS 359 TCS 359 301305-73-7 C18H20N2O4S
Ilomastat Ilomastat 142880-36-2 C20H28N4O4
2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine  hydrate  hydrochloride 2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride 694433-59-5 C20H21N3O2
BI-D1870 BI-D1870 501437-28-1 C19H23F2N5O2
SCH772984 SCH772984 942183-80-4 C33H33N9O2
6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine 6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine 934353-76-1 C21H25N7
RO4929097 RO4929097 847925-91-1 C22H20F5N3O3
PD318088 PD318088 391210-00-7 C16H13BrF3IN2O4
N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]benzamidehydrochloride N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]benzamidehydrochloride 313553-47-8 C18H16N2OS
3-(Aminocarbonyl)-β-(3-cyclohexylpropyl)-N-hydroxy-1,2,4-oxadiazole-5-propanamide 3-(Aminocarbonyl)-β-(3-cyclohexylpropyl)-N-hydroxy-1,2,4-oxadiazole-5-propanamide 348622-88-8 C15H24N4O4
IWP-2 IWP-2 686770-61-6 C22H18N4O2S3
Hesperadin Hesperadin 422513-13-1 C29H32N4O3S
PIK-294 PIK-294 900185-02-6 C28H23N7O2
Golvatinib (E7050) Golvatinib (E7050) 928037-13-2 C33H37F2N7O4
VU 0364439 VU 0364439 1246086-78-1 C18H13Cl2N3O3S
LY 2874455 LY 2874455 1254473-64-7 C21H19Cl2N5O2
LY2090314 LY2090314 603288-22-8 C28H25FN6O3
AZD5363 AZD5363 1143532-39-1 C21H25ClN6O2
Birinapant Birinapant 1260251-31-7 C42H56F2N8O6
P-5091 P-5091 882257-11-6 C12H7Cl2NO3S2
CK-636 CK-636 442632-72-6 C16H16N2OS
SB 225002 SB 225002 182498-32-4 C13H10BrN3O4
SKI II SKI II 312636-16-1 C15H11ClN2OS
TTNPB (Arotinoid Acid) TTNPB (Arotinoid Acid) 71441-28-6 C24H28O2
Batimastat Batimastat 130370-60-4 C23H31N3O4S2
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- 2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- 404951-53-7 C22H25N3O3
ZOTAROLIMUS ZOTAROLIMUS 221877-54-9 C52H79N5O12
2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE 2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE 189224-48-4 C13H14N2O
SANT-1 SANT-1 304909-07-7 C23H27N5
S3I-201 S3I-201 501919-59-1 C16H15NO7S
LY411575 LY411575 209984-57-6 C26H23F2N3O4
WZ8040 WZ8040 1214265-57-2 C24H25ClN6OS
JAK3 Inhibitor JAK3 Inhibitor 211555-04-3 C16H14BrN3O3
N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea 1144068-46-1 C27H33N7O4
Insulin-like Growth Factor-1 Receptor Inhibitor Insulin-like Growth Factor-1 Receptor Inhibitor 468740-43-4 C25H26ClN5O3
HMN-214 HMN-214 173529-46-9 C22H20N2O5S
MK8245 MK8245 1030612-90-8 C17H16BrFN6O4
5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine 5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine 475488-23-4 C28H31N5O
OSI-420 OSI-420 183320-51-6 C21H22ClN3O4
VU 0357121 VU 0357121 433967-28-3 C17H17F2NO2
N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea 1207360-89-1 C24H32N6O3
Nepicastat  hydrochloride Nepicastat hydrochloride 170151-24-3 C14H16ClF2N3S
BMN 673 BMN 673 1207456-01-6 C19H14F2N6O
VX-661 VX-661 1152311-62-0 C26H27F3N2O6
HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase
Copyright © 2016 ChemicalBook All rights reserved.